CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences , Shanghai, China.
School of Life Sciences and Technology, Shanghai Tech University , Shanghai, China.
Autophagy. 2020 Jul;16(7):1236-1247. doi: 10.1080/15548627.2019.1659654. Epub 2019 Aug 30.
Macroautophagy/autophagy is an evolutionarily conserved intracellular process that recycles and degrades intracellular components to sustain homeostasis in response to deficiency of nutrients or growth factors. PAQR3 is a newly discovered tumor suppressor that also regulates autophagy induced by nutrient starvation via AMPK and MTORC1 signaling pathways. In this study, we investigated whether PAQR3 modulates EGFR-mediated autophagy and whether such regulation is associated with the tumor suppressive activity of PAQR3. PAQR3 is able to inhibit the and growth of non-small cell lung cancer (NSCLC) cells. PAQR3 potentiates autophagy induced by EGFR inhibitor erlotinib. Knockdown of PAQR3 abrogates erlotinib-mediated reduction of BECN1 interaction with autophagy inhibitory proteins RUBCN/Rubicon and BCL2. PAQR3 blocks the interaction of BECN1 with the activated form of EGFR and inhibits tyrosine phosphorylation of BECN1. Furthermore, inhibition of autophagy by knocking down ATG7 abrogates the tumor suppressive activity of PAQR3 in NSCLC cells. Collectively, these data indicate that PAQR3 suppresses tumor progression of NSCLC cells through modulating EGFR-regulated autophagy.
AKT: thymoma viral proto-oncogene; ATG5: autophagy related 5; ATG7: autophagy related 7; ATG14: autophagy related 14; BCL2: B cell leukemia/lymphoma 2; BECN1: beclin 1; CCK-8: cell counting kit-8; CQ: chloroquine diphosphate; DMEM: Dulbecco's modified Eagle's medium; EdU: 5-ethynyl-2'-deoxyuridine; EGFR: epidermal growth factor receptor; FBS: fetal bovine serum; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; IgG: Immunoglobulin G; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; MTOR: mechanistic target of rapamycin kinase; MTORC1: mechanistic target of rapamycin kinase complex 1; MTT: thiazolyl blue tetrazolium bromide; NSCLC: Non-small cell lung cancer; MAP2K/MEK: mitogen-activated protein kinase kinase; MAPK/ERK: mitogen-activated protein kinase; PAQR3: progestin and adipoQ receptor family member 3; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; PIK3R4/VPS15: phosphoinositide-3-kinase regulatory subunit 4; PRKAA/AMPK: protein kinase, AMP-activated alpha catalytic; RUBCN: rubicon autophagy regulator; RPS6: ribosomal protein S6; RAS: Ras proto-oncogene; RAF: Raf proto-oncogene; TKI: tyrosine kinase inhibitor; TUBA4A: tubulin alpha 4a; UVRAG: UV radiation resistance associated.
探讨 PAQR3 是否调节表皮生长因子受体(EGFR)介导的自噬,以及这种调节是否与 PAQR3 的肿瘤抑制活性有关。
使用细胞计数试剂盒-8(CCK-8)和 EdU 增殖实验检测 PAQR3 对非小细胞肺癌(NSCLC)细胞增殖的影响。通过蛋白质印迹法和免疫荧光染色检测 PAQR3 对自噬相关蛋白表达和自噬体形成的影响。通过免疫共沉淀实验检测 PAQR3 与 EGFR 和 Beclin1 的相互作用。通过Western blot 检测 EGFR 抑制剂 erlotinib 诱导的自噬和 AKT/mTOR 信号通路的激活。
PAQR3 能够抑制 NSCLC 细胞的增殖和克隆形成。PAQR3 增强了 erlotinib 诱导的自噬。PAQR3 敲低消除了 erlotinib 介导的 BECN1 与自噬抑制蛋白 RUBCN/Rubicon 和 BCL2 的相互作用。PAQR3 阻断了 BECN1 与激活形式的 EGFR 的相互作用,并抑制了 BECN1 的酪氨酸磷酸化。此外,通过敲低 ATG7 抑制自噬会消除 PAQR3 在 NSCLC 细胞中的肿瘤抑制活性。
PAQR3 通过调节 EGFR 调节的自噬抑制 NSCLC 细胞的肿瘤进展。